Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update

Go back to Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update
(NASDAQ: KYMR) Delayed: 87.34 +4.38 (5.28%)
Previous Close $82.96    52 Week High
Open $82.53    52 Week Low
Day High $88.58    P/E N/A 
Day Low $82.53    EPS
Volume 301,277